{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:37Z","timestamp":1790712457794,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2023 IDI-IRCCS"],"award-info":[{"award-number":["RC 2023 IDI-IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2024 IDI-IRCCS"],"award-info":[{"award-number":["RC 2024 IDI-IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2019-12368888"],"award-info":[{"award-number":["RF-2019-12368888"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2019-12368888"],"award-info":[{"award-number":["RF2019-12368888"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-M4C2-I 1.3"],"award-info":[{"award-number":["PNRR-M4C2-I 1.3"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["A0375-2020-36568 UTV-IDI"],"award-info":[{"award-number":["A0375-2020-36568 UTV-IDI"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["A0375-2020-36568 UTV-IDI"],"award-info":[{"award-number":["A0375-2020-36568 UTV-IDI"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is a chronic skin disease characterized by keratinocyte hyperproliferation and inflammation, largely driven by the cytokines IL-22 and interferon (IFN)-\u03b3. These cytokines activate the signal transducer and activator of transcription (STAT) 3 and STAT1 molecular pathways, leading to abnormal proliferation, impaired differentiation, and increased production of inflammatory mediators in keratinocytes. While the IL-22\/STAT3 pathway primarily promotes de-differentiation in keratinocytes, IFN-\u03b3\/STAT1-3 signaling induces pronounced inflammation, despite exerting antiproliferative effects on these cells. Recent research has highlighted the role of serine\/glycine metabolism in the pathogenesis of psoriasis, by supporting T cell and keratinocyte proliferation. Furthermore, pharmacological inhibition of serine catabolism through targeting serine hydroxymethyltranferase (SHMT)1\/2 enzymes reduced the infiltration of inflammatory cells in the skin of the imiquimod-induced mouse model of psoriasis. This study investigates the role of serine catabolism in psoriasis, focusing on its influence on keratinocyte proliferation and inflammation. We examined how pharmacological inhibition of SHMT1\/2, mediated by a folate-competitive cell-permeable inhibitor Serine Hydroxymethyltransferase INhibitor 1 (SHIN1), affects keratinocyte proliferation and inflammatory signaling pathways in response to psoriasis-associated cytokines IL-22 and IFN-\u03b3, using both in vitro and ex vivo models of the disease. We found that SHIN1 reduced keratinocyte proliferation, particularly under IL-22 stimulation, and restored differentiation in ex vivo psoriasis skin explants by reversing the effects of IL-22. SHIN1 also inhibited IFN-\u03b3-induced expression of pro-inflammatory genes (e.g.,\n                    <jats:italic>CXCL10<\/jats:italic>\n                    ,\n                    <jats:italic>CXCL9<\/jats:italic>\n                    ,\n                    <jats:italic>CCL5<\/jats:italic>\n                    ,\n                    <jats:italic>CCL2<\/jats:italic>\n                    ,\n                    <jats:italic>IL-6<\/jats:italic>\n                    ) and reduced STAT3 activation, with only modest effects on STAT1 and extracellular signal-regulated kinase 1\/2 activation. In psoriasis explants, SHIN1 decreased the expression of Ki67, Keratin 16, and pro-inflammatory cytokines including IL-17A, IL-22, and IFN-\u03b3. These findings support the therapeutic potential of SHIN1 as a metabolism-targeted agent for psoriasis and other cytokine-mediated skin disorders, providing a rationale for further exploration of novel treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03138-3","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:16:53Z","timestamp":1778246213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting serine\/glycine metabolism to attenuate IFN-\u03b3- and IL-22-driven inflammation and hyperproliferation in psoriasis"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura","family":"Mercurio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sergio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Scarponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-4854","authenticated-orcid":false,"given":"Mara","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-445X","authenticated-orcid":false,"given":"Angela","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-4825","authenticated-orcid":false,"given":"Eleonora","family":"Candi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-6833","authenticated-orcid":false,"given":"Cristina","family":"Albanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"crossref","unstructured":"Albanesi C. Immunology of Psoriasis. In: Clinical Immunology: Principles and Practice, 2022. 6th Edn. Chapter 64, 824\u2013831.","DOI":"10.1016\/B978-0-7020-8165-1.00064-2"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.3390\/ijms221910841","volume":"22","author":"A Orsmond","year":"2021","unstructured":"Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M. Skin barrier dysregulation in psoriasis. Int J Mol Sci. 2021;22:10841.","journal-title":"Int J Mol Sci"},{"key":"3138_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6621","volume":"5","author":"R Lande","year":"2014","unstructured":"Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, et al. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun. 2014;5:5621.","journal-title":"Nat Commun"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"3138_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","volume":"34","author":"MA Lowes","year":"2013","unstructured":"Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG. The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013;34:174\u201381.","journal-title":"Trends Immunol"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"C Albanesi","year":"2018","unstructured":"Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunol. 2018;9:1\u20137.","journal-title":"Front Immunol"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","volume":"26","author":"D Cibrian","year":"2020","unstructured":"Cibrian D, de la Fuente H, S\u00e1nchez-Madrid F. Metabolic Pathways That Control Skin Homeostasis and Inflammation. Trends Mol Med. 2020;26:975\u201386.","journal-title":"Trends Mol Med"},{"key":"3138_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13:81.","journal-title":"Cell Death Dis"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"1201912","DOI":"10.3389\/fmolb.2023.1201912","volume":"10","author":"E Sarandi","year":"2023","unstructured":"Sarandi E, Krueger-Krasagakis S, Tsoukalas D, Sidiropoulou P, Evangelou G, Sifaki M, et al. Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy. Front Mol Biosci. 2023;10:1201912.","journal-title":"Front Mol Biosci"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.phrs.2019.104352","volume":"149","author":"JD Zeng","year":"2019","unstructured":"Zeng JD, Wu WKK, Wang HY, Li XX. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Pharm Res. 2019;149:104352.","journal-title":"Pharm Res"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2023.12.001","volume":"36","author":"MJ McBride","year":"2024","unstructured":"McBride MJ, Hunter CJ, Zhang Z, TeSlaa T, Xu X, Ducker GS, et al. Glycine homeostasis requires reverse SHMT flux. Cell Metab. 2024;36:103\u201315.","journal-title":"Cell Metab"},{"key":"3138_CR12","doi-asserted-by":"publisher","first-page":"129607","DOI":"10.1016\/j.ijbiomac.2024.129607","volume":"260","author":"D Wu","year":"2024","unstructured":"Wu D, Zhang K, Khan FA, Pandupuspitasari NS, Guan K, Sun F, et al. A comprehensive review on signaling attributes of serine and serine metabolism in health and disease. Int J Biol Macromol. 2024;260:129607.","journal-title":"Int J Biol Macromol"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.celrep.2014.04.045","volume":"7","author":"CF Labuschagne","year":"2014","unstructured":"Labuschagne CF, van den Broek NJF, Mackay GM, Vousden KH, Maddocks ODK. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014;7:1248\u201358.","journal-title":"Cell Rep"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"13464","DOI":"10.1074\/jbc.RA119.008743","volume":"294","author":"TWM Fan","year":"2019","unstructured":"Fan TWM, Bruntz RC, Yang Y, Song H, Chernyavskaya Y, Deng P, et al. De novo synthesis of serine and glycine fuels purine nucleotide biosynthesis in human lung cancer tissues. J Biol Chem. 2019;294:13464\u201377.","journal-title":"J Biol Chem"},{"key":"3138_CR15","doi-asserted-by":"publisher","first-page":"eabm7902","DOI":"10.1126\/sciadv.abm7902","volume":"8","author":"A Cappello","year":"2022","unstructured":"Cappello A, Mancini M, Madonna S, Rinaldo S, Paone A, Scarponi C, et al. Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms. Sci Adv. 2022;8:eabm7902.","journal-title":"Sci Adv"},{"key":"3138_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"ODK Maddocks","year":"2013","unstructured":"Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2013;493:542\u20136.","journal-title":"Nature"},{"key":"3138_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","volume":"25","author":"EH Ma","year":"2017","unstructured":"Ma EH, Bantug G, Griss T, Condotta S, Johnson RM, Samborska B, et al. Serine Is an Essential Metabolite for Effector T Cell Expansion. Cell Metab. 2017;25:345\u201357.","journal-title":"Cell Metab"},{"key":"3138_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350.","journal-title":"Nature"},{"key":"3138_CR19","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","volume":"4","author":"J Ye","year":"2014","unstructured":"Ye J, Fan J, Venneti S, Wan YW, Pawel BR, Zhang J, et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 2014;4:1406\u201317.","journal-title":"Cancer Discov"},{"key":"3138_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzol\u00e1 F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39:191\u20138.","journal-title":"Trends Biochem Sci"},{"key":"3138_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41420-023-01398-x","volume":"9","author":"A Cappello","year":"2023","unstructured":"Cappello A, Zuccotti A, Mancini M, Tosetti G, Fania L, Ricci F, et al. Serine and one-carbon metabolism sustain non-melanoma skin cancer progression. Cell Death Discov. 2023;9:102.","journal-title":"Cell Death Discov"},{"key":"3138_CR22","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.1706617114","volume":"114","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Li SHJ, et al. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proc Natl Acad Sci. 2017;114:11404\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"3138_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1159\/000524119","volume":"238","author":"F Prignano","year":"2022","unstructured":"Prignano F, Donetti E. Looking at interleukin-22 from a new dermatological perspective: from epidermal homeostasis to its role in chronic skin diseases. Dermatology. 2022;238:829\u201336.","journal-title":"Dermatology"},{"key":"3138_CR24","doi-asserted-by":"publisher","first-page":"7897263","DOI":"10.1155\/2018\/7897263","volume":"2018","author":"M Morelli","year":"2018","unstructured":"Morelli M, Scarponi C, Mercurio L, Facchiano F, Pallotta S, Madonna S, et al. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis. J Immunol Res. 2018;2018:7897263.","journal-title":"J Immunol Res"},{"key":"3138_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","volume":"25","author":"R Sestito","year":"2011","unstructured":"Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 2011;25:916\u201327.","journal-title":"FASEB J"},{"key":"3138_CR26","first-page":"e27080","volume":"2","author":"NC Reich","year":"2013","unstructured":"Reich NC. STATs get their move on. JAKSTAT. 2013;2:e27080.","journal-title":"JAKSTAT"},{"key":"3138_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11:43\u20139.","journal-title":"Nat Med"},{"key":"3138_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"S Sano","year":"2008","unstructured":"Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50:1\u201314.","journal-title":"J Dermatol Sci"},{"key":"3138_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk K, Witte E, Wallace E, D\u00f6cke WD, Kunz S, Asadullah K, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis. Eur J Immunol. 2006;36:1309\u201323.","journal-title":"Eur J Immunol"},{"key":"3138_CR30","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950\u20137.","journal-title":"Nat Immunol"},{"key":"3138_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","volume":"9","author":"E Volpe","year":"2008","unstructured":"Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hup\u00e9 P, Barillot E, et al. A critical function for transforming growth factor-\u03b2, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol. 2008;9:650\u20137.","journal-title":"Nat Immunol"},{"key":"3138_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/jid.2011.458","volume":"132","author":"LM Johnson-Huang","year":"2012","unstructured":"Johnson-Huang LM, Su\u00e1rez-Fari\u00f1as M, Pierson KC, Fuentes-Duculan J, Cueto I, Lentini T, et al. A single intradermal injection of IFN-\u03b3 induces an inflammatory state in both non-lesional psoriatic and healthy skin. J Invest Dermatol. 2012;132:1177\u201387.","journal-title":"J Invest Dermatol"},{"key":"3138_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","volume":"25","author":"C Albanesi","year":"2007","unstructured":"Albanesi C, De Pit\u00e0 O, Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007;25:581\u20138.","journal-title":"Clin Dermatol"},{"key":"3138_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1084\/jem.164.4.1013","volume":"164","author":"AB Gottlieb","year":"1986","unstructured":"Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM. Expression of HLA-DR molecules by keratinocytes, and presence of langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med. 1986;164:1013\u201328.","journal-title":"J Exp Med"},{"key":"3138_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/138920010791196328","volume":"11","author":"C Albanesi","year":"2010","unstructured":"Albanesi C, Pastore S. Pathobiology of Chronic Inflammatory Skin Diseases: Interplay Between Keratino-cytes and Immune Cells as a Target for Anti-Inflammatory Drugs. Curr Drug Metab. 2010;11:210\u201327.","journal-title":"Curr Drug Metab"},{"key":"3138_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00441-006-0173-9","volume":"325","author":"M Hern\u00e1ndez-Quintero","year":"2006","unstructured":"Hern\u00e1ndez-Quintero M, Kuri-Harcuch W, Gonz\u00e1lez Robles A, Castro-Mu\u00f1ozledo F. Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture. Cell Tissue Res. 2006;325:77\u201390.","journal-title":"Cell Tissue Res"},{"key":"3138_CR37","first-page":"893","volume":"32","author":"A Chiricozzi","year":"2017","unstructured":"Chiricozzi A, Romanelli M, Panduri S, Donetti E, Prignano F. Relevance of in vitro 3-D skin models in dissecting cytokine contribution to psoriasis pathogenesis. Histol Histopathol. 2017;32:893\u20138.","journal-title":"Histol Histopathol"},{"key":"3138_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1529-8019.2007.00135.x","volume":"20","author":"C Arolyn","year":"2007","unstructured":"Arolyn C, Angert AB, Elissa M, Ostner IC. Methotrexate in dermatology. Dermatol Ther. 2007;20:216\u201328.","journal-title":"Dermatol Ther"},{"key":"3138_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1042\/BST20190803","volume":"48","author":"AM Alqarni","year":"2020","unstructured":"Alqarni AM, Zeidler MP. How does methotrexate work? Biochem Soc Trans. 2020;48:559\u201367.","journal-title":"Biochem Soc Trans"},{"key":"3138_CR40","doi-asserted-by":"publisher","first-page":"41679","DOI":"10.1074\/jbc.M406413200","volume":"279","author":"Y Qing","year":"2004","unstructured":"Qing Y, Stark GR. Alternative activation of STAT1 and STAT3 in response to interferon-\u03b3. J Biol Chem. 2004;279:41679\u201385.","journal-title":"J Biol Chem"},{"key":"3138_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.24452","volume":"60","author":"SH Kok","year":"2009","unstructured":"Kok SH, Hong CY, Kuo MYP, Wang CC, Hou KL, Lin YT, et al. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: An implication for the pathogenesis of arthritis. Arthritis Rheum. 2009;60:1451\u201362.","journal-title":"Arthritis Rheum"},{"key":"3138_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","volume":"92","author":"P Przanowski","year":"2014","unstructured":"Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, Kaza B, et al. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J Mol Med. 2014;92:239\u201354.","journal-title":"J Mol Med"},{"key":"3138_CR43","doi-asserted-by":"publisher","first-page":"154862","DOI":"10.1016\/j.cyto.2019.154862","volume":"126","author":"G Thiel","year":"2020","unstructured":"Thiel G, Ulrich M, Mukaida N, R\u00f6ssler OG. Regulation of stimulus-induced interleukin-8 gene transcription in human adrenocortical carcinoma cells \u2013 Role of AP-1 and NF-\u03baB. Cytokine. 2020;126:154862.","journal-title":"Cytokine"},{"key":"3138_CR44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1021\/cb500407d","volume":"9","author":"E Butturini","year":"2014","unstructured":"Butturini E, Darra E, Chiavegato G, Cellini B, Cozzolino F, Monti M, et al. S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation. ACS Chem Biol. 2014;9:1885\u201393.","journal-title":"ACS Chem Biol"},{"key":"3138_CR45","doi-asserted-by":"publisher","first-page":"e20174","DOI":"10.1371\/journal.pone.0020174","volume":"6","author":"E Butturini","year":"2011","unstructured":"Butturini E, Cavalieri E, de Prati AC, Darra E, Rigo A, Shoji K, et al. Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation. PLoS ONE. 2011;6:e20174.","journal-title":"PLoS ONE"},{"key":"3138_CR46","doi-asserted-by":"publisher","first-page":"e107904","DOI":"10.1371\/journal.pone.0107904","volume":"9","author":"C Scarponi","year":"2014","unstructured":"Scarponi C, Butturini E, Sestito R, Madonna S, Cavani A, Mariotto S, et al. Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide. PLoS ONE. 2014;9:e107904.","journal-title":"PLoS ONE"},{"key":"3138_CR47","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.biocel.2012.08.016","volume":"44","author":"M Kurdi","year":"2012","unstructured":"Kurdi M, Sivakumaran V, Duh\u00e9 RJ, Aon MA, Paolocci N, Booz GW. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes. Int J Biochem Cell Biol. 2012;44:2106\u201315.","journal-title":"Int J Biochem Cell Biol"},{"key":"3138_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vph.2007.11.006","volume":"48","author":"YC Liu","year":"2008","unstructured":"Liu YC, Hsieh CW, Weng YC, Chuang SH, Hsieh CY, Wung BS. Sulforaphane inhibition of monocyte adhesion via the suppression of ICAM-1 and NF-\u03baB is dependent upon glutathione depletion in endothelial cells. Vasc Pharm. 2008;48:54\u201361.","journal-title":"Vasc Pharm"},{"key":"3138_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.lungcan.2009.07.017","volume":"68","author":"JY Hung","year":"2010","unstructured":"Hung JY, Hsu YL, Ni WC, Tsai YM, Yang CJ, Kuo PL, et al. Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells. Lung Cancer. 2010;68:355\u201365.","journal-title":"Lung Cancer"},{"key":"3138_CR50","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","volume":"128","author":"S Pastore","year":"2008","unstructured":"Pastore S, Mascia F, Mariani V, Girolomoni G. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol. 2008;128:1365\u201374.","journal-title":"J Invest Dermatol"},{"key":"3138_CR51","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.molcel.2024.01.002","volume":"84","author":"C Wang","year":"2024","unstructured":"Wang C, Chen Q, Chen S, Fan L, Gan Z, Zhao M, et al. Serine synthesis sustains macrophage IL-1\u03b2 production via NAD+-dependent protein acetylation. Mol Cell. 2024;84:744\u201359.","journal-title":"Mol Cell"},{"key":"3138_CR52","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/eji.201445052","volume":"45","author":"L Nardinocchi","year":"2015","unstructured":"Nardinocchi L, Sonego G, Passarelli F, Avitabile S, Scarponi C, Failla CM, et al. Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer. Eur J Immunol. 2015;45:922\u201331.","journal-title":"Eur J Immunol"},{"key":"3138_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1143-3","volume":"9","author":"L Mercurio","year":"2018","unstructured":"Mercurio L, Morelli M, Scarponi C, Eisenmesser EZ, Doti N, Pagnanelli G, et al. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis. 2018;9:1104.","journal-title":"Cell Death Dis"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03138-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:18:11Z","timestamp":1782893891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03138-3","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its amendments. It was approved by the ethics committee of IDI-IRCCS (Rome, Italy). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"289"}}